Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Two Researchers Work to Unravel Mysteries of the Aging Brain
Uncategorized

Two Researchers Work to Unravel Mysteries of the Aging Brain

By medwebApr 1, 2007
Share
Facebook Twitter Email

April 12, 2007

Two Researchers Work to Unravel Mysteries of the Aging Brain

Americans are living longer thanks to advances in treating major diseases, but the new longevity exposes them to a greater threat to the aging brain’s vulnerability to degenerative disorders.

Two Northwestern University researchers working to unravel the mysteries of neurodegenerative disorders and their threat to health and the quality of lives are Catherine S. Woolley, PhD, and Mark D. Bevan, PhD.

Dr. Woolley, professor of neurobiology and physiology in the Weinberg College of Arts and Sciences, has been using reproductive hormones as tools to understand brain plasticity and brain function. Laboratory testing on rats has shown that the female sex hormone estrogen increases the number and complexity of the synaptic connections in the hippocampus, suggesting that the hormone can help protect the brain from degeneration.

Her research opens doors to deeper understanding of many diseases, including Alzheimer’s and epilepsy. Her newest research studies the effects of addiction on the brain’s neural circuitry. Dr. Woolley’s experiments prepare the way to finding drugs that mimic estrogen’s neuroprotective benefits without activating all of its hormonal effects and that can be used on both men and women.

Dr. Woolley’s work is funded by the National Institutes of Health’s National Institute on Drug Abuse and the National Institute on Neurological Disorders and Stroke (NINDS). She was also the first Northwestern faculty member to be awarded the W.M. Keck Foundation Award for Distinguished Young Scholars in Medical Research, which she received in 2002.

Dr. Bevan, professor of physiology at the Feinberg School of Medicine, and his laboratory study the brain’s basal ganglia and their dysfunction in movement disorders such as Parkinson’s disease (PD). The researchers utilize a combination of electrophysiology, two-photon imaging, and electron microscopy.

Normal neuronal activity in the basal ganglia is arrhythmic, poorly correlated, and related to movement in a highly complex manner. In PD, neuronal activity is strongly correlated, and low-frequency rhythms develop that are associated with the disease’s characteristic tremor and other motor symptoms. Dr. Bevan’s strategy for understanding this transformation has been to first determine the principles underlying normal neuronal activity and then determine how dopamine depletion in PD generates the pathological activity pattern.

One recent therapy for PD is deep brain stimulation of the subthalamic nucleus, which greatly ameliorates the symptoms of PD. Dr. Bevan hopes that greater understanding of the mechanisms underlying the therapeutic efficacy of this treatment will facilitate the discovery of pharmaceutical or other nonsurgical treatments that are associated with less risk to the patient.

His laboratory is funded by NINDS and the National Parkinson Foundation and forms part of Northwestern University’s Morris K. Udall Center of Excellence for Parkinson’s Disease Research.

(Adapted from an article in the Office for Research Annual Report 2006)

Share. Facebook Twitter Email

Related Posts

Lurie Cancer Center Receives Merit Extension from NCI

Oct 20, 2021

Drug Combination May Reduce Risk of Leukemia Relapse

Mar 26, 2020

Rewriting the Role of a Transcription Factor

Mar 19, 2020

Comments are closed.

Latest News

Sex-Specific Mechanisms for Major Depressive Disorder Identified in Response to Dysregulated Stress Hormones

Mar 23, 2023

Pre-Surgery Immunotherapy May Increase Survival in Advanced Melanoma

Mar 23, 2023

Hormone Therapy Plus Current Treatments Improves Survival in Prostate Cancer

Mar 22, 2023

How ChatGPT Has, and Will Continue to, Transform Scientific Research

Mar 21, 2023

New Directions for HIV Treatment

Mar 21, 2023
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20230317_NM651
20230317_NM610
20230317_NM569
20230317_NM537
20230317_NM331
20230317_NM323
20230317_NM316
20230317_NM336
20230317_NM626
20230317_NM662
20230317_NM655
20230317_NM642

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2023 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.